Posts Tagged ‘U.S.’

American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep …
DALLAS, July 14 /PRNewswire-USNewswire/ — After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs …

Avandia’s heart risks under review in U.S.
A U.S. review reinforces potential ties between the Type 2 diabetes pill Avandia and heart attack and death, opening the door for U.S. government action.

(AFX UK Focus) 2010-06-15 18:41 U.S. FDA advisory meetings through Dec 15
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL ITEMS EDT/GMT until Nov. 7, when EST/GMT resumes. For more information on the FDA’s Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm